<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25492868</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>290</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.</ArticleTitle><Pagination><StartPage>3198</StartPage><EndPage>3208</EndPage><MedlinePgn>3198-208</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.624536</ELocationID><Abstract><AbstractText>Hand-foot-and-mouth disease (HFMD) remains a major health concern in the Asia-Pacific regions, and its major causative agents include human enterovirus 71 (EV71) and coxsackievirus A16. A desirable vaccine against HFMD would be multivalent and able to elicit protective responses against multiple HFMD causative agents. Previously, we have demonstrated that a thermostable recombinant EV71 vaccine candidate can be produced by the insertion of a foreign peptide into the BC loop of VP1 without affecting viral replication. Here we present crystal structures of two different naturally occurring empty particles, one from a clinical C4 strain EV71 and the other from its recombinant virus containing an insertion in the VP1 BC loop. Crystal structure analysis demonstrated that the inserted foreign peptide is well exposed on the particle surface without significant structural changes in the capsid. Importantly, such insertions do not seem to affect the virus uncoating process as illustrated by the conformational similarity between an uncoating intermediate of another recombinant virus and that of EV71. Especially, at least 18 residues from the N terminus of VP1 are transiently externalized. Altogether, our study provides insights into vaccine development against HFMD.</AbstractText><CopyrightInformation>&#xa9; 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guang-Chuan</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China, and Qiushi Academy for Advanced Studies, Zhejiang University, Hangzhou 310027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ya-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>From the Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jian-Feng</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Cheng-Feng</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China, and qincf@bmi.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China, rongchen@ips.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>1POV</AccessionNumber><AccessionNumber>3VBU</AccessionNumber><AccessionNumber>4N53</AccessionNumber><AccessionNumber>4RQP</AccessionNumber><AccessionNumber>4RR3</AccessionNumber><AccessionNumber>4RS5</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058425">Vaccines, Virus-Like Particle</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058425" MajorTopicYN="N">Vaccines, Virus-Like Particle</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Crystal Structure</Keyword><Keyword MajorTopicYN="N">Infectious Disease</Keyword><Keyword MajorTopicYN="N">Vaccine</Keyword><Keyword MajorTopicYN="N">Vaccine Development</Keyword><Keyword MajorTopicYN="N">Virus Structure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25492868</ArticleId><ArticleId IdType="pmc">PMC4318995</ArticleId><ArticleId IdType="doi">10.1074/jbc.M114.624536</ArticleId><ArticleId IdType="pii">S0021-9258(20)49174-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McMinn P. C. (2012) Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr. Opin. Virol. 2, 199&#x2013;205</Citation><ArticleIdList><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Cao R. Y., Chen R., Mo L., Han J. F., Wang X., Xu X., Jiang T., Deng Y. Q., Lyu K., Zhu S. Y., Qin E. D., Tang R., Qin C. F. (2013) Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions. Proc. Natl. Acad. Sci. U.S.A. 110, 7619&#x2013;7624</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651461</ArticleId><ArticleId IdType="pubmed">23589862</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin A., Wychowski C., Couderc T., Crainic R., Hogle J., Girard M. (1988) Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J. 7, 2839&#x2013;2847</Citation><ArticleIdList><ArticleId IdType="pmc">PMC457076</ArticleId><ArticleId IdType="pubmed">2460345</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray M. G., Kuhn R. J., Arita M., Kawamura N., Nomoto A., Wimmer E. (1988) Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc. Natl. Acad. Sci. U.S.A. 85, 3203&#x2013;3207</Citation><ArticleIdList><ArticleId IdType="pmc">PMC280172</ArticleId><ArticleId IdType="pubmed">2834736</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans D. J., McKeating J., Meredith J. M., Burke K. L., Katrak K., John A., Ferguson M., Minor P. D., Weiss R. A., Almond J. W. (1989) An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339, 385&#x2013;388, 340</Citation><ArticleIdList><ArticleId IdType="pubmed">2542797</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeates T. O., Jacobson D. H., Martin A., Wychowski C., Girard M., Filman D. J., Hogle J. M. (1991) Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera. EMBO J. 10, 2331&#x2013;2341</Citation><ArticleIdList><ArticleId IdType="pmc">PMC452928</ArticleId><ArticleId IdType="pubmed">1651227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J., Smith A. D., Geisler S. C., Ma X., Arnold G. F., Arnold E. (2002) Crystal structure of a human rhinovirus that displays part of the HIV-1 V3 loop and induces neutralizing antibodies against HIV-1. Structure 10, 999&#x2013;1011</Citation><ArticleIdList><ArticleId IdType="pubmed">12121655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T., Porta C., Lomonossoff G., Johnson J. E. (1996) Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 &#x212b; resolution. Fold Des. 1, 179&#x2013;187</Citation><ArticleIdList><ArticleId IdType="pubmed">9079380</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavappa R., Syed R., Flore O., Icenogle J. P., Filman D. J., Hogle J. M. (1994) Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 &#x212b; resolution. Protein Sci. 3, 1651&#x2013;1669</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2142606</ArticleId><ArticleId IdType="pubmed">7849583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansardi D. C., Morrow C. D. (1995) Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions. J. Virol. 69, 1540&#x2013;1547</Citation><ArticleIdList><ArticleId IdType="pmc">PMC188747</ArticleId><ArticleId IdType="pubmed">7853487</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson M. F., Baltimore D. (1968) Morphogenesis of poliovirus. I. Association of the viral RNA with coat protein. J. Mol. Biol. 33, 369&#x2013;378</Citation><ArticleIdList><ArticleId IdType="pubmed">4302632</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttman N., Baltimore D. (1977) Morphogenesis of poliovirus. IV. existence of particles sedimenting at 150S and having the properties of provirion. J. Virol. 23, 363&#x2013;367</Citation><ArticleIdList><ArticleId IdType="pmc">PMC515838</ArticleId><ArticleId IdType="pubmed">196114</ArticleId></ArticleIdList></Reference><Reference><Citation>Marongiu M. E., Pani A., Corrias M. V., Sau M., La Colla P. (1981) Poliovirus morphogenesis. I. Identification of 80S dissociable particles and evidence for the artifactual production of procapsids. J. Virol. 39, 341&#x2013;347</Citation><ArticleIdList><ArticleId IdType="pmc">PMC171342</ArticleId><ArticleId IdType="pubmed">6268826</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bouvier G. L. (1955) The modification of poliovirus antigens by heat and ultraviolet light. Lancet 269, 1013&#x2013;1016</Citation><ArticleIdList><ArticleId IdType="pubmed">13272322</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel B., Akacem O., Crainic R., Couillin P., Horodniceanu F. (1983) Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions. Virology 126, 707&#x2013;710</Citation><ArticleIdList><ArticleId IdType="pubmed">6190311</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C. C., Guo M. S., Lin F. H., Hsiao K. N., Chang K. H., Chou A. H., Wang Y. C., Chen Y. C., Yang C. S., Chong P. C. (2011) Purification and characterization of enterovirus 71 viral particles produced from Vero cells grown in a serum-free microcarrier bioreactor system. PLoS One 6, e20005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094384</ArticleId><ArticleId IdType="pubmed">21603631</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Peng W., Ren J., Hu Z., Xu J., Lou Z., Li X., Yin W., Shen X., Porta C., Walter T. S., Evans G., Axford D., Owen R., Rowlands D. J., Wang J., Stuart D. I., Fry E. E., Rao Z. (2012) A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 19, 424&#x2013;429</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R. J., Rossmann M. G. (2012) Crystal structure of human enterovirus 71. Science 336, 1274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuente J. O., Lee H., Yoder J. D., Shingler K. L., Carnegie M. S., Yoder J. L., Ashley R. E., Makhov A. M., Conway J. F., Hafenstein S. (2013) Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J. Virol. 87, 7637&#x2013;7645</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3700288</ArticleId><ArticleId IdType="pubmed">23637404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu K., Ding J., Han J. F., Zhang Y., Wu X. Y., He Y. L., Qin C. F., Chen R. (2014) Human enterovirus 71 uncoating captured at atomic resolution. J. Virol. 88, 3114&#x2013;3126</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3957924</ArticleId><ArticleId IdType="pubmed">24352461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingler K. L., Yoder J. L., Carnegie M. S., Ashley R. E., Makhov A. M., Conway J. F., Hafenstein S. (2013) The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog. 9, e1003240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605244</ArticleId><ArticleId IdType="pubmed">23555253</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C. C., Chou A. H., Lien S. P., Lin H. Y., Liu S. J., Chang J. Y., Guo M. S., Chow Y. H., Yang W. S., Chang K. H., Sia C., Chong P. (2011) Identification and characterization of a cross-neutralization epitope of enterovirus 71. Vaccine 29, 4362&#x2013;4372</Citation><ArticleIdList><ArticleId IdType="pubmed">21501643</ArticleId></ArticleIdList></Reference><Reference><Citation>Otwinowski Z., Minor W. (1997) Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307&#x2013;326</Citation><ArticleIdList><ArticleId IdType="pubmed">27754618</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L., Rossmann M. G. (1997) Rotation function calculations with GLRF program. Methods Enzymol. 276, 594&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">9048382</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams P. D., Afonine P. V., Bunk&#xf3;czi G., Chen V. B., Davis I. W., Echols N., Headd J. J., Hung L. W., Kapral G. J., Grosse-Kunstleve R. W., McCoy A. J., Moriarty N. W., Oeffner R., Read R. J., Richardson D. C., Richardson J. S., Terwilliger T. C., Zwart P. H. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213&#x2013;221</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P., Lohkamp B., Scott W. G., Cowtan K. (2010) Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486&#x2013;501</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLano W. L. (2010) The PyMOL Molecular Graphics System, version 1.3r1, Schrodinger, LLC, New York</Citation></Reference><Reference><Citation>Pettersen E. F., Goddard T. D., Huang C. C., Couch G. S., Greenblatt D. M., Meng E. C., Ferrin T. E. (2004) UCSF Chimera&#x2014;a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605&#x2013;1612</Citation><ArticleIdList><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo D. G., Ang R. X., Alonso S., Chow V. T., Quak S. H., Poh C. L. (2008) Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots. Clin. Microbiol. Infect. 14, 286&#x2013;288</Citation><ArticleIdList><ArticleId IdType="pubmed">18076666</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy M. D., Stanley S. K., Amis E. J., Becker M. L. (2008) Identification of a highly specific hydroxyapatite-binding peptide using phage display. Adv. Mater. 20, 1830&#x2013;1836</Citation></Reference><Reference><Citation>Foo D. G., Alonso S., Phoon M. C., Ramachandran N. P., Chow V. T., Poh C. L. (2007) Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 125, 61&#x2013;68</Citation><ArticleIdList><ArticleId IdType="pubmed">17222936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley L. A., Sternberg M. J. (2009) Protein structure prediction on the web: a case study using the Phyre server. Nat. Protoc. 4, 363&#x2013;371</Citation><ArticleIdList><ArticleId IdType="pubmed">19247286</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricks C. E., Icenogle J. P., Hogle J. M. (1985) Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. J. Virol. 54, 856&#x2013;859</Citation><ArticleIdList><ArticleId IdType="pmc">PMC254874</ArticleId><ArticleId IdType="pubmed">2987536</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke K. L., Dunn G., Ferguson M., Minor P. D., Almond J. W. (1988) Antigen chimaeras of poliovirus as potential new vaccines. Nature 332, 81&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">2450279</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins O., Cason J., Burke K. L., Lunney D., Gillen A., Patel D., McCance D. J., Almond J. W. (1990) An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16. J. Virol. 64, 1201&#x2013;1206</Citation><ArticleIdList><ArticleId IdType="pmc">PMC249234</ArticleId><ArticleId IdType="pubmed">2154604</ArticleId></ArticleIdList></Reference><Reference><Citation>Colb&#xe8;re-Garapin F., Christodoulou C., Crainic R., Garapin A. C., Candrea A. (1988) Addition of a foreign oligopeptide to the major capsid protein of poliovirus. Proc. Natl. Acad. Sci. U.S.A. 85, 8668&#x2013;8672</Citation><ArticleIdList><ArticleId IdType="pmc">PMC282521</ArticleId><ArticleId IdType="pubmed">2460875</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdin A. D., Wimmer E. (1989) Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II. J. Virol. 63, 5251&#x2013;5257</Citation><ArticleIdList><ArticleId IdType="pmc">PMC251190</ArticleId><ArticleId IdType="pubmed">2479772</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent C. I., Kirkegaard K. (1995) RNA binding properties of poliovirus subviral particles. J. Virol. 69, 13&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC188543</ArticleId><ArticleId IdType="pubmed">7983702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>